GSMA Launches Inclusive Tech Lab
24.9.2019 11:00:00 EEST | Business Wire | Press release
The GSMA today announced the launch of the GSMA Inclusive Tech Lab, which will take a hands-on approach to research, testing and development of the inclusive technologies of the future. The Bill and Melinda Gates Foundation has provided three years of funding for the GSMA Inclusive Tech Lab, and will sit on the Advisory Group alongside industry representatives including GoPay, IDEMIA, KaiOS, Mowali, Telenor, the University of Washington, VEON and Vodafone.
“In launching the GSMA Inclusive Tech Lab, we are taking a bold new step to support and stimulate innovation through greater experimentation and a willingness to take risks,” said John Giusti, Chief Regulatory Officer, GSMA. “The GSMA Mobile for Development programme has already had a direct impact on improving the lives of 58 million people. The Lab will allow our team of dedicated ‘technopreneurs’ the opportunity to take a hands-on approach to break down the barriers to economic and social inclusion further.”
“We are proud to be collaborating with the GSMA and funding the Inclusive Tech Lab to strategize, build and pilot technologies to support the industry with innovations to drive financial inclusion for the poorest,” said Matt Bohan, Senior Programme Officer, Financial Services for the Poor at The Bill and Melinda Gates Foundation. “The Lab will enable us to create and explore products, from interoperability platforms to standardised APIs and more, that will help the industry to drive innovation to include poor people at a whole new pace and scale.”
The Lab will work on a range of areas that drive inclusion. These will comprise expanding the openness and interoperability of payment systems, service accessibility for women and vulnerable populations, and digital identities for unregistered people, as well as other topics of relevance. The GSMA, together with industry stakeholders, will establish and share proofs of concept aimed at increasing financial and digital inclusion for underserved groups.
The services of the Lab will be three-fold; research, innovation projects and technological assets (e.g. web-based test environments). The Lab will benefit from guidance received from leading industry figures making up its global Advisory Group, who will help to assess, prioritise, shape and contribute towards potential project ideas received by the Lab. Following direction from the Advisory Group, projects deemed feasible will be further researched and developed. The Lab will build readily usable products and insights up to proof-of-concept (and potentially support an initial commercial launch, as appropriate). Critically, the Lab will ensure learnings and Lab-developed solutions will be available to the broader industry, with the first results available to the industry in the first quarter of 2020.
Giusti concluded, “Today there are challenges of expanding access to financial services, bridging the digital services gap for women and vulnerable user groups, and providing digital identity solutions for the one billion individuals with no form of ID. These challenges drive our activity as we work on the transformative digital innovations of tomorrow.”
To find out more about the GSMA Inclusive Tech Lab, and how you can contribute, please go to the following link: www.gsma.com/lab
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190924005109/en/
Contact information
Media Contacts:
Gearóid Cashman
+44 79 7679 0169
GCashman@webershandwick.com
GSMA Press Office
pressoffice@gsma.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
